A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

Clinical trial NCT06113328 · TERMINATED

Trial details

NCT number: NCT06113328
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-segmental Vitiligo

Start date: 2023-11-27
Primary completion: 2025-03-20
Enrollment: 169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.